Literature DB >> 6667861

Inhibition of experimental intraocular proliferation with intravitreal 5-fluouracil.

S Binder, B Riss, C Skorpik, W Kulnig.   

Abstract

5-Fluorouracil was used to inhibit experimental intraocular proliferation in rabbit eyes, produced by homologe fibroblast implantation. Two different concentrations were used, 1 and 5 mg in a single intravitreal injection. The eyes were followed up over 4 weeks. Proliferation and resulting traction detachment was reduced from 75% to 30% in the 1-mg 5-fluouracil group. In addition, we observed retinal and vascular changes in a considerable number of eyes treated with 1 mg and much more pronounced alterations in most of the eyes treated with 5 mg fluouracil.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667861     DOI: 10.1007/bf02133851

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  The treatment of massive vitreous retraction by the separation of pre-retinal membranes using liquid silicone.

Authors:  J D Scott
Journal:  Mod Probl Ophthalmol       Date:  1975

2.  Glucocorticosteroid inhibition of intraocular proliferation after injury.

Authors:  Y Tano; D B Chandler; B W McCuen; R Machemer
Journal:  Am J Ophthalmol       Date:  1981-02       Impact factor: 5.258

3.  Intravitreal autotransplantation of fibroblasts.

Authors:  G Sugita; Y Tano; R Machemer; G Abrams; A Claflin; G Fiorentino
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

4.  The effect of penicillamine on posttraumatic vitreous proliferation.

Authors:  J F Weiss; M Belkin
Journal:  Am J Ophthalmol       Date:  1981-11       Impact factor: 5.258

5.  [Liquid silicone in amotio surgery (II). Report on 280 cases - further development of the technic].

Authors:  R Zivojnović; D A Mertens; E Peperkamp
Journal:  Klin Monbl Augenheilkd       Date:  1982-12       Impact factor: 0.700

6.  Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide.

Authors:  Y Tano; D Chandler; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-12       Impact factor: 5.258

7.  Inhibition of intraocular proliferations with intravitreal corticosteroids.

Authors:  Y Tano; G Sugita; G Abrams; R Machemer
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

8.  Fluorouracil for the treatment of massive periretinal proliferation.

Authors:  M S Blumenkranz; A Ophir; A J Claflin; A Hajek
Journal:  Am J Ophthalmol       Date:  1982-10       Impact factor: 5.258

9.  [Is there drug alternative in the treatment of massive periretinal proliferation? (author's transl)].

Authors:  S Binder
Journal:  Klin Monbl Augenheilkd       Date:  1981-12       Impact factor: 0.700

10.  Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits.

Authors:  J Rootman; J Tisdall; G Gudauskas; A Ostry
Journal:  Arch Ophthalmol       Date:  1979-12
  10 in total
  5 in total

Review 1.  Proliferative vitreoretinopathy--is it anything more than wound healing at the wrong place?

Authors:  M Weller; P Wiedemann; K Heimann
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

2.  Radiation therapy in proliferative vitreoretinopathy. A prospective randomized study.

Authors:  S Binder; M Bonnet; M Velikay; J P Gerard; U Stolba; A Wedrich; H Hohenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

3.  Experimental study on drug therapy of "traction retinal detachment" after posterior penetrating eye injury in the rabbit.

Authors:  W Behrens-Baumann; M Vogel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  Inhibition of intraocular proliferation by homoharringtonine. An experimental study.

Authors:  J P Li; C Z Hu; S Q Zeng; J M Ren; H R Wei
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

5.  Liposome-encapsulated 3H-5FU in rabbits.

Authors:  P Fishman; G A Peyman; R Hendricks; S L Hui
Journal:  Int Ophthalmol       Date:  1989-09       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.